Stock Events

Stock Events

AI Financial 

$0.82
124
-$0.01-1.2% Tuesday 13:30

Statistics

Day High
0.87
Day Low
0.8
52W High
10.26
52W Low
0.75
Volume
2,153,800
Avg. Volume
-
Mkt Cap
103.48M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 22
$0.06
Jan 22
$0.46
Oct 21
$0.35
Jul 21
$0.35
Apr 21
$0.17
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

19MayExpected
Q4 0
Q1 2025
Q2 2025
Q4 2025
Next
-0.36
-0.29
-0.21
-0.14
Expected EPS
-0.14
Actual EPS
N/A

Financials

-49.83%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
25.06MRevenue
-12.49MNet Income

Analyst Ratings

27Average Price Target
The highest estimate is 28.00.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
90%
Hold
10%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ALTS. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a global pharmaceutical company that competes with JanOne in the development of treatments for various diseases, including those JanOne targets with its non-opioid pain management solutions.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical segment, competes in developing medications and treatments that can overlap with JanOne's focus areas, including pain management.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie operates in the pharmaceuticals sector, focusing on innovative therapies, directly competing with JanOne in areas like chronic pain treatment.
Merck
MRK
Mkt Cap277.02B
Merck is involved in the development and manufacturing of drugs that address serious health issues, competing with JanOne in the pharmaceutical space, especially in pain management solutions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.7B
Teva Pharmaceutical Industries specializes in generic and specialty medicines, including pain management, making it a competitor to JanOne in the non-opioid pain relief market.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that produces drugs in various therapeutic areas, including pain, competing with JanOne's mission to offer alternative pain solutions.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb is a biopharmaceutical company that develops medicines in several therapeutic areas, potentially competing with JanOne in the area of pain management.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly and Company focuses on pharmaceuticals in areas that could compete with JanOne, especially considering their work on pain and chronic conditions.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline is a healthcare company that produces pharmaceuticals across various areas, including pain relief, making it a competitor to JanOne.
Sanofi
SNY
Mkt Cap110.4B
Sanofi is a global life sciences company that offers a broad range of medicines, including those for pain management, competing with JanOne's focus on non-opioid solutions.

Holdings

Regions

Sectors

About

ALT5 Sigma Corporation operates a next generation blockchain platform. It engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. The company's products include ALT 5 Prime, an electronic over-the-counter trading platform to buy and sell digital assets; and ALT 5 Pay that enables payment processors to accept digital assets as payments, as well as make payment in digital assets. It is also involved in the developing of solutions for opioid crisis. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.
Show more...
CEO
Mr. Antonios Isaac
Employees
10
Country
United States
ISIN
US47089W1045

Listings

F
DE
5AR1.F
MU
DE
5AR1.MU
STU
DE
5AR1.STU
XNAS
US
AIFC

0 Comments

Share your thoughts

FAQ

What is AI Financial stock price today?▼
The current price of ALTS is $0.82 USD — it has decreased by -1.2% in the past 24 hours. Watch AI Financial stock price performance more closely on the chart.
What is AI Financial stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange AI Financial stocks are traded under the ticker ALTS.
Is AI Financial stock price growing?▼
ALTS stock has fallen by -4.65% compared to the previous week, the month change is a -29.31% fall, over the last year AI Financial has showed a -85.64% decrease.
What is AI Financial market cap?▼
Today AI Financial has the market capitalization of 103.48M
When is the next AI Financial earnings date?▼
AI Financial is going to release the next earnings report on May 19, 2026.
What is AI Financial revenue for the last year?▼
AI Financial revenue for the last year amounts to 25.06M USD.
What is AI Financial net income for the last year?▼
ALTS net income for the last year is -12.49M USD.
Does AI Financial pay dividends?▼
Yes, ALTS dividends are paid quarterly. The last dividend per share was 0.06 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does AI Financial have?▼
As of May 06, 2026, the company has 10 employees.
In which sector is AI Financial located?▼
AI Financial operates in the Health & Wellness sector.
When did AI Financial complete a stock split?▼
The last stock split for AI Financial was on April 22, 2019 with a ratio of 1:5.
Where is AI Financial headquartered?▼
AI Financial is headquartered in Las Vegas, United States.